Abstract: A green concrete composition comprising: a binder component comprising Portland cement, natural basaltic volcanic ash pozzolan, and colloidal nano-sized silica particles; an aggregate component comprising fine aggregates and coarse aggregates; water; and a super plasticizer.

Abstract: Methods and systems are disclosed that include receiving problem information from a user interface at a resolution identification system, receiving product information at the resolution identification system, and performing machine learning analysis of the problem information and the product information. The machine learning analysis produces one or more model outputs, and is performed by a machine learning system of the resolution identification system, using one or more machine learning models. Each of the one or more machine learning models produces a corresponding one of the one or more model outputs. Such a method can further include generating resolution information by performing an action identification operation using the one or more model outputs, and outputting the resolution information from the resolution identification system. The resolution information is output to the user interface.

Abstract: Provided herein are compositions, methods, systems and/or kits for preventing and/or treating neoplasms using at least one modulator selected from quercetin, sodium phenyl butyrate and epigallocatechin-3-gallate in combination with one or more anti-cancer agents. The compositions, methods, systems and/or kits are used to prevent and/or treat neoplasms that are resistant to the one or more anti-cancer agents when administered alone.

Abstract: A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The patient is subjected to a hyperbaric environment of substantially pure oxygen. A predetermined dose of one or more HDACI substances is administered to the patient. In addition, glycolitic inhibitors may also be administered. Dosages, pressures, and durations are selected as described herein to have a therapeutic effect on the patient.

Abstract: A wearable electronic device is disclosed. The device can include a support structure and an electronic component disposed in or on the support structure. A heat exchanger element can be thermally coupled with the electronic component, the heat exchanger element comprising a fluid inlet port and a fluid outlet port. A first conduit can be fluidly connected to the fluid inlet port of the heat exchanger, the first conduit configured to convey, to the heat exchanger, liquid at a first temperature. A second conduit can be fluidly connected to the fluid outlet port of the heat exchanger, the second conduit configured to convey, away from the heat exchanger, liquid at a second temperature different from the first temperature.

Abstract: Provided herein are compositions, methods, systems and/or kits for preventing and/or treating neoplasms using at least one of quercetin, sodium phenyl butyrate and epigallocatechin-3-gallate in combination with one or more anti-cancer agents. The compositions, methods, systems and/or kits are used to prevent and/or treat neoplasms that are resistant to the one or more anti-cancer agents when administered alone.

Abstract: Various methods, apparatuses/systems, and media for automatically generating fully integrated regression and system testing (FIRST) analytics are disclosed. A processor accesses a production database to obtain production data associated with an application, and accesses a user acceptance testing (UAT) database to obtain UAT data associated with the application. The processor generates gap data on test coverage based on comparing the production data with the UAT data; analyzes the generated gap data; automatically generates, in response to analyzing the generated gap data, executable full coverage of test scenarios for testing the application; and automatically executes testing of the application based on the generated test scenarios.

Abstract: Various methods, apparatuses/systems, and media for automatically generating fully integrated regression and system testing (FIRST) analytics are disclosed. A processor accesses a production database to obtain production data associated with an application, and accesses a user acceptance testing (UAT) database to obtain UAT data associated with the application. The processor generates gap data on test coverage based on comparing the production data with the UAT data; analyzes generated gap data; automatically generates, in response to analyzing the generated gap data, executable full coverage of test scenarios for testing the application; and automatically executes testing of the application based on the generated test scenarios.

Abstract: Provided herein are compositions, methods, systems and/or kits for preventing and/or treating neoplasms using at least one of quercetin, sodium phenyl butyrate and epigallocatechin-3-gallate in combination with one or more anti-cancer agents. The compositions, methods, systems and/or kits are used to prevent and/or treat neoplasms that are resistant to the one or more anti-cancer agents when administered alone.

Abstract: Provided herein are compositions, methods, systems and/or kits for preventing and/or treating neoplasms using at least one modulator selected from quercetin, sodium phenyl butyrate and epigallocatechin-3-gallate in combination with one or more anti-cancer agents. The compositions, methods, systems and/or kits are used to prevent and/or treat neoplasms that are resistant to the one or more anti-cancer agents when administered alone. Also provided are nanoformulations based on nanoparticles comprising one or more anti-cancer agents and/or one or more modulators for preventing and/or treating neoplasms.

Abstract: Methods and systems are disclosed that include the identification of one or more actions in an action flow that is intended to resolve a problem, and to guide a user through the one or more actions of such an action flow, dynamically adjusting the action flow during such guidance and/or subsequent thereto, using machine learning techniques. In some embodiments, such a method can include. for example, receiving outcome information at a machine learning system (where the outcome information is associated with an action of an action flow and the action flow comprises a plurality of actions), generating update information (where the update information is generated by the machine learning system based, at least in part, on the outcome information), and updating action information of the action (where the action information is updated based, at least in part, on the update information).

Abstract: A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The patient is subjected to a hyperbaric environment of substantially pure oxygen. A predetermined dose of one or more HDACI substances is administered to the patient. In addition, glycolitic inhibitors may also be administered. Dosages, pressures, and durations are selected as described herein to have a therapeutic effect on the patient.

Abstract: Provided herein are compositions, methods, systems and/or kits for preventing and/or treating neoplasms using at least one modulator selected from quercetin, sodium phenyl butyrate and epigallocatechin-3-gallate in combination with one or more anti-cancer agents. The compositions, methods, systems and/or kits are used to prevent and/or treat neoplasms that are resistant to the one or more anti-cancer agents when administered alone.

Abstract: Methods and systems are disclosed that include receiving problem information from a user interface at a resolution identification system, receiving product information at the resolution identification system, and performing machine learning analysis of the problem information and the product information. The machine learning analysis produces one or more model outputs, and is performed by a machine learning system of the resolution identification system, using one or more machine learning models. Each of the one or more machine learning models produces a corresponding one of the one or more model outputs. Such a method can further include generating resolution information by performing an action identification operation using the one or more model outputs, and outputting the resolution information from the resolution identification system. The resolution information is output to the user interface.

Abstract: A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The patient is subjected to a hyperbaric environment of substantially pure oxygen. A predetermined dose of one or more HDACI substances is administered to the patient. In addition, glycolitic inhibitors may also be administered. Dosages, pressures, and durations are selected as described herein to have a therapeutic effect on the patient.

Abstract: Provided herein are compositions, methods, systems and/or kits for preventing and/or treating neoplasms using at least one modulator selected from quercetin, sodium phenyl butyrate and epigallocatechin-3-gallate in combination with one or more anti-cancer agents. The compositions, methods, systems and/or kits are used to prevent and/or treat neoplasms that are resistant to the one or more anti-cancer agents when administered alone. Also provided are nanoformulations based on nanoparticles with one or more anti-cancer agents and/or one or more modulators for preventing and/or treating neoplasms.

Abstract: A wearable electronic device is disclosed. The device can include a support structure and an electronic component disposed in or on the support structure. A heat exchanger element can be thermally coupled with the electronic component, the heat exchanger element comprising a fluid inlet port and a fluid outlet port. A first conduit can be fluidly connected to the fluid inlet port of the heat exchanger, the first conduit configured to convey, to the heat exchanger, liquid at a first temperature. A second conduit can be fluidly connected to the fluid outlet port of the heat exchanger, the second conduit configured to convey, away from the heat exchanger, liquid at a second temperature different from the first temperature.

Abstract: Provided herein are compositions, methods, systems and/or kits for preventing and/or treating neoplasms using at least one of quercetin, sodium phenyl butyrate and epigallocatechin-3-gallate in combination with one or more anti-cancer agents. The compositions, methods, systems and/or kits are used to prevent and/or treat neoplasms that are resistant to the one or more anti-cancer agents when administered alone.

Abstract: A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The patient is subjected to a hyperbaric environment of substantially pure oxygen. A predetermined dose of one or more HDACI substances is administered to the patient. In addition, glycolitic inhibitors may also be administered. Dosages, pressures, and durations are selected as described herein to have a therapeutic effect on the patient.

Abstract: A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The patient is subjected to a hyperbaric environment of substantially pure oxygen. A predetermined dose of one or more HDACI substances is administered to the patient. In addition, glycolitic inhibitors may also be administered. Dosages, pressures, and durations are selected as described herein to have a therapeutic effect on the patient.